Attention Inventors and Patentees

Help is on the way.

In Plight of the Patentee, those who are trying to dismantle the patent system are taken to task. The stories included in Plight of the Patentee call out:

  • The media, politicians, and academicians who gratuitously grandstand at the expense of inventors and scheme to deracinate patents from the entrepreneurial ecosystem.
  • Incompetent and obstructionist patent examiners who subject patent applicants to endless volleys of prosecutorial shenanigans.
  • State attorneys general whose mafia-style intimidation tactics trounce on the notion of preemption and require patentees to post reverse bonds as a condition of advancing their litigation.
  • The corrupt judges in foreign countries who pressure patentees to accept minimal lump-sum royalties for perpetual licenses, thereby giving infringers the veneer of legitimacy.
  • The kangaroo-court-inspired government tribunals designed to commit the mass execution of patents.
  • District courts presided over by judges that admittedly have no understanding of the technologies at hand and that utilize eligibility issues as docket clearing mechanisms.
  • The Court of Appeals for the Federal Circuit which regularly extinguishes decades of excruciating sacrifice and millions of dollars of investment with one-word verdicts.
  • The Supreme Court for its consistent stream of anti-patent decisions, for its fixation on remedying the supposed ills caused by “patent trolls” even when no such conceivable issues are anywhere near the cases under review, and for its supinely gorging on propaganda pieces masquerading around as amicus curiae briefs.
  • The Helter-Skelter potpourri of vexatious litigation tactics waged against patentees by infringers whose creativity is limited to their ability to slither out of paying damages awards.
  • The depravity of infringers, such as the consumer electronics company that refused to pay a fraction of the royalties it owned a patentee, even when that patentee vowed to dedicated such royalties to organizations researching cures for pancreatic cancer—the very disease that claimed the life of that company’s iconic founder.
  • The duplicity of parasitic infringers who introduce cancer-causing agents into their knock-offs for which rightful inventors are held liable.
  • The duplicity of parasitic infringers who exhaust patentees with litigation until the patentee pays to settle tortious interferences suits brought by infringers.
  • The duplicity of parasitic infringers who fabricate prior art and then force legitimate patent applicants to present such fabrications to patent examiners under the fear of being subject to inequitable conduct charges based on failing to disclose prior art.
  • The duplicity of parasitic infringers who instigate IRS audits against patentees and subcontract out the manufacturing of their infringing items to Chinese-prison laborers.
  • The duplicity of parasitic infringers who agree to sell only remaining infringing products and then continue to produce infringing products for years and years.
  • The infliction of pain that ripples through patentees’ supply chains when infringement occurs. For instance, infringers impregnate manufacturers working for patentees with excess inventory as sales are lost to knock-off artists.
  • The mendacity of large organizations that unlawfully interfere with solo inventors applying for grant funding and then prepare forged cease-and-desist letters from faux law firms for purposes of intimidating individual inventors from competing with them.
  • The cut-throat business tactics that financing companies compel inventors to accept. Requirements for funding extend beyond hundreds of thousands of dollars in monthly interest payments and include inventors losing their shares in their companies as well as being terminated from those companies.

About the Author:

David WanetickDavid Wanetick is an internationally recognized valuation expert with an expertise in valuing patents, intangible assets, and emerging technologies. The valuations David performs are primarily conducted in the context of capital raises, negotiating licensing agreements, university spin-offs, mergers and acquisitions, patent sales, tax issues, and litigation support. His work is performed on behalf of emerging, mid- and large-sized companies, national laboratories, technology transfer offices, inventors, venture capitalists, and private equity firms. More can be learned about his patent valuation work here.

David is an investment banker (Managing Director) at Merit Harbor Capital and is involved in brokering patents. He is the CEO of the Business Development Academy. The Business Development Academy runs the Institute for Strategic Negotiations which runs the world-renowned two-day Enhanced Negotiating Strategies seminar and maintains the world’s largest library of negotiating titles.

The Business Development Academy also runs the Certified Patent Valuation Analyst designation which is the world leader in training attendees how to value patents, intangible assets, and emerging technologies. The CPVA program has provided its training programs all over the United States, Canada, the United Kingdom, the Netherlands, Belgium, Germany, Spain, Dubai, China, Denmark, Thailand, Singapore, Kuwait, Malaysia, Hong Kong, India, the Philippines and Israel. Over one thousand of the most accomplished patent professionals have taken the CPVA program.

CPVAs hail from all over the world and from companies and organizations including IBM, DSM, Solvay, McGill University, the United States Department of Energy, Boehringer Ingelheim, Microsoft, Johnson & Johnson, Bayer, Hewlett-Packard, Doosan, Fujitsu, Shell Oil, Intellectual Ventures, Cisco, DuPont, Schlumberger, British Telecom, Lockheed Martin, Coca-Cola, Oracle, Baker Hughes, AT&T, Visa, Panasonic, General Electric, Samsung, and Infosys. (For a list of current CPVA training sessions, please see this link.) More than 250 glowing testimonials from past attendees from all over the world can be viewed here.

The cost for a softcover copy of Plight of the Patentee is $30. The cost for a hardcover copy of Plight of the Patentee is $40.

Contact Neomi Barazani at neomi@bdacademy.com to order.

Start typing and press Enter to search

Shopping Cart

No products in the cart.